Background: Nearly 20% of cancers are associated with obesity. However, specific BMI thresholds with which these cancers are most likely to develop have not been identified. The objective of our study was to identify whether BMI thresholds or "cut-points" exist for 14 cancers associated with obesity. Methods: Patients aged 18-75 who had clinical encounters spanning a 2-year period at an integrated U.S. health system from 2008-2018 were identified from the electronic health record. Patients who were underweight (BMI , 18.5 kg/m 2 ), pregnant, previously diagnosed with cancer, or had bariatric surgery were excluded. The 1-year incidences of 14 cancers were identified using ICD-9/10 codes. Associations between BMI and cancer incidence were evaluated with Mann-Whitney tests. To identify cutpoints, BMI was treated as a screening test for each cancer, with sensitivity and specificity calculated for each 0.5 increment of BMI. Cut-points were defined as BMI thresholds that maximized Youden's index (sensitivity+specificity-1), with an area under the receiver operating curve (AUROC).0.6. Results: We included 207,036 patients in our study; 53.3% patients were female. The average BMI was 29.1 kg/m 2 . Statistically significant associations between BMI and cancer incidence were identified for breast, kidney, uterine, thyroid, and pancreatic cancers (Table) . We identified BMI cut-points for 2 of the 14 cancers: uterine (34.5 kg/m 2 , AUROC50.72) and kidney (29.0 kg/m 2 , AUROC50.62) cancer. Conclusions: The risk of developing uterine and kidney cancer increases significantly as patients transition between overweight and class 1 obesity. Targeted screening and early weight loss interventions for these patients should be strongly considered.
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Methods:
In order to determine the cardiac changes in ventricular mass, ventricular contractility and left ventricular shortening fraction (LVSF), we retrospectively reviewed the two-dimensional echocardiographic parameters of patients with obesity who underwent BS at our institution. We compared the Results before and after surgery. Results: A total of 41 patients met the inclusion criteria. The majority were females 57.5% (23) with an average age of 63.5 + 12.11. The estimated BMI loss at 12 months was 48.95 + 28.91. The left ventricular mass was 234.9 + 88.11grams before and 181.58 + 52.72 after BS (P50.002). The left ventricular mass index was 101.3 + 38.34 g/m2 before versus 86.70 + 26.65 after BS (p50.005). The LVSF was 31.05 + 8.82 % before and 36.34 + 8.21 after (p50.007). We found a good correlation between the decrease in LVM index and BMI after BS (p50.03). Conclusions: Rapid weight loss after Bariatric Surgery Results in a decrease of LVM index as well as an improvement in the left ventricular muscle contractility parameters.Our results suggest there that there is a left ventricular remodeling and improvement of the heart dynamics following rapid weight loss. Further studies are needed to better assess these findings.
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CONCURRENT OPERATIONS DURING BARIATRIC SURGERY: AN ANALYSIS OF THE MBSAQIP DATABASE 2015-2017 Benjamin Clapp 1 ; Isaac Lee 2 ; Katherine Aguirre 2 ; Evan Liggett 2 ; Michael Cutshall 2 ; Bryson Tudor 2 ; Alan Tyroch 2 ; 1 Benjamin Clapp MD PA, El Paso TX; 2 Texas Tech HSC Paul Foster School of Med, El Paso TX Background: Bariatric surgery is the most effective treatment of morbid obesity, diabetes mellitus and many other diseases. The American College of Surgeons tracks 30 day outcomes using the Metabolic and Bariatric Surgery Accreditation Quality Initiative Program (MBSAQIP) database. We examined the short term outcomes of patients that undergo bariatric surgery concomitantly with other operations such as hernia repairs and cholecystectomy to determine the safety of this practice. Methods: The MBSAQIP Public Use File for 2015-2017 was examined for differences in primary bariatric operations vs concurrent procedures (CP). We only used the Current Procedural Terminology (CPT) codes for gastric bypass (GB -CPT 43644) and sleeve gastrectomy (SG -CPT 43775) for our primary bariatric
